We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Quality of Warning Letters Is Not What It Used to Be, Industry Says
Quality of Warning Letters Is Not What It Used to Be, Industry Says
July 9, 2010
Ever since FDA Commissioner Margaret Hamburg ended prior legal review, the quality of warning letters coming out of the agency has declined, industry says, and now the agency is evaluating that policy change.